Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

PSMA PET/CT for prostate cancer patients after focal therapy: a single center retrospective analysis

Mahbod Jafarvand, Andrea Farolfi, Matthias Benz, LOIC DJAILEB, Riccardo Mei, Johannes Czernin, Leonard Marks and Jeremie Calais
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1241;

Article Information

vol. 64 no. supplement 1 P1241
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.
Copyright & Usage 
© 2023

Author Information

  1. Mahbod Jafarvand1,
  2. Andrea Farolfi2,
  3. Matthias Benz1,
  4. LOIC DJAILEB3,
  5. Riccardo Mei4,
  6. Johannes Czernin5,
  7. Leonard Marks6 and
  8. Jeremie Calais1
  1. 1University of California, Los Angeles
  2. 2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles
  3. 3UCLA Ahmanson Biological Imaging Center
  4. 4Universita' degli Studi di Bologna - Policlinico S. Orsola-Malpighi
  5. 5Ahmanson Translational Theranostics Division, Pharmacology, University of California
  6. 6David Geffen School of Medicine at UCLA

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023100
Sep 20231600
Oct 20232000
Nov 20232600
Dec 20231700
Jan 20242400
Feb 20241700
Mar 2024500
Apr 20245600
May 20242700
Jun 20244900
Jul 202412500
Aug 202411200
Sep 20243500
Oct 20243500
Nov 20242700
Dec 20242000
Jan 20252700
Feb 20251700
Mar 20251900
Apr 20256400
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section